| South Lyon Medical Center | |
| 213 S Whitacre/po Box 940, Yerington, Nevada 89447 | |
| (775) 781-3761 | |
| Not Available |
| Name | South Lyon Medical Center |
|---|---|
| Type | Critical Access Hospital |
| Location | 213 S Whitacre/po Box 940, Yerington, Nevada |
| Ownership | Government - Hospital District or Authority |
| Emergency Services | Yes |
| Medicare ID (CCN) | 291314 |
| NPI Number | 1316014764 |
| Organization Name | SOUTH LYON MEDICAL CENTER |
| Address | 213 S Whitacre St, Yerington, NV 89447 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 775-463-2301 |
News Archive
Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.
The BRICS Hearing Aids, Hearing Implants and Hearing Diagnostic market has witnessed a substantial growth of 4.8 per cent in last few years and it is likely to register higher growth than expected.
New research in individuals with schizotypal personalities - people characterized by odd behavior and language but who are not psychotic or schizophrenic - offers the first neurological evidence that these individuals are more creative than normal or fully schizophrenic people, and rely more heavily on the right sides of their brains than the general population to access their creativity.
EarlySense Ltd., the market leader in contact-free monitoring, announced today that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10M. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber.
› Verified 1 days ago
| NPI Number | 1376917302 |
| Organization Name | SOUTH LYON HEALTH CENTER, INC. |
| Doing Business As | SOUTH LYON MEDICAL CENTER |
| Address | 213 S Whitacre St, Yerington, NV 89447 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 775-463-2301 |
News Archive
Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.
The BRICS Hearing Aids, Hearing Implants and Hearing Diagnostic market has witnessed a substantial growth of 4.8 per cent in last few years and it is likely to register higher growth than expected.
New research in individuals with schizotypal personalities - people characterized by odd behavior and language but who are not psychotic or schizophrenic - offers the first neurological evidence that these individuals are more creative than normal or fully schizophrenic people, and rely more heavily on the right sides of their brains than the general population to access their creativity.
EarlySense Ltd., the market leader in contact-free monitoring, announced today that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10M. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber.
› Verified 1 days ago
| NPI Number | 1740347715 |
| Organization Name | SOUTH LYON HEALTH CENTER, INC. |
| Doing Business As | SOUTH LYON MEDICAL CENTER |
| Address | 213 S. Whitacre, Yerington, NV 89447 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 775-463-2301 |
News Archive
Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.
The BRICS Hearing Aids, Hearing Implants and Hearing Diagnostic market has witnessed a substantial growth of 4.8 per cent in last few years and it is likely to register higher growth than expected.
New research in individuals with schizotypal personalities - people characterized by odd behavior and language but who are not psychotic or schizophrenic - offers the first neurological evidence that these individuals are more creative than normal or fully schizophrenic people, and rely more heavily on the right sides of their brains than the general population to access their creativity.
EarlySense Ltd., the market leader in contact-free monitoring, announced today that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10M. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber.
› Verified 1 days ago
| NPI Number | 1841251279 |
| Organization Name | SOUTH LYON HEALTH CENTER, INC. |
| Doing Business As | SOUTH LYON MEDICAL CENTER |
| Address | 213 S. Whitacre, Yerington, NV 89447 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 775-463-2301 |
News Archive
Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.
The BRICS Hearing Aids, Hearing Implants and Hearing Diagnostic market has witnessed a substantial growth of 4.8 per cent in last few years and it is likely to register higher growth than expected.
New research in individuals with schizotypal personalities - people characterized by odd behavior and language but who are not psychotic or schizophrenic - offers the first neurological evidence that these individuals are more creative than normal or fully schizophrenic people, and rely more heavily on the right sides of their brains than the general population to access their creativity.
EarlySense Ltd., the market leader in contact-free monitoring, announced today that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10M. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber.
› Verified 1 days ago
| NPI Number | 1932160363 |
| Organization Name | SOUTH LYON HEALTH CENTER, INC. |
| Doing Business As | SOUTH LYON MEDICAL CENTER |
| Address | 213 S. Whitacre, Yerington, NV 89447 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 775-463-2301 |
News Archive
Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.
The BRICS Hearing Aids, Hearing Implants and Hearing Diagnostic market has witnessed a substantial growth of 4.8 per cent in last few years and it is likely to register higher growth than expected.
New research in individuals with schizotypal personalities - people characterized by odd behavior and language but who are not psychotic or schizophrenic - offers the first neurological evidence that these individuals are more creative than normal or fully schizophrenic people, and rely more heavily on the right sides of their brains than the general population to access their creativity.
EarlySense Ltd., the market leader in contact-free monitoring, announced today that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10M. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber.
› Verified 1 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.
The BRICS Hearing Aids, Hearing Implants and Hearing Diagnostic market has witnessed a substantial growth of 4.8 per cent in last few years and it is likely to register higher growth than expected.
New research in individuals with schizotypal personalities - people characterized by odd behavior and language but who are not psychotic or schizophrenic - offers the first neurological evidence that these individuals are more creative than normal or fully schizophrenic people, and rely more heavily on the right sides of their brains than the general population to access their creativity.
EarlySense Ltd., the market leader in contact-free monitoring, announced today that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10M. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber.
› Verified 1 days ago
South Lyon Medical Center Critical Access Hospital Location: 213 S Whitacre/po Box 940, Yerington, Nevada 89447 Phone: (775) 781-3761 |